• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:刘广桢,张雷,刘琦,肖镜.不同药典X射线衍射技术应用体系的比较[J].药学研究,2026,45(9):1047-1051[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 227次   下载 207次 本文二维码信息
码上扫一扫!
不同药典X射线衍射技术应用体系的比较
刘广桢1,张雷1,刘琦1,肖镜2
字体:加大+|默认|缩小-
(1.山东省食品药品检验研究院,山东省中药标准创新与质量评价工程实验室,工业和信息化部产业技术基础公共服务平台,山东 济南 250101;2.中国药品检定研究院,北京 102629)
摘要:
本文通过比较中美欧药典X射线衍射(XRD)技术应用体系,系统揭示了该技术在药品质量控制中的核心价值与标准发展逻辑。中美欧药典均收载粉末X射线衍射法,且均明确其在晶态物质定性与定量分析中的核心应用,形成了XRD法在药品质控中应用的统一基础规范,在晶型药物鉴别、矿物药石棉检查、药用辅料功能性质控等领域形成国际共识,体现了XRD法在药品质控中的核心价值。建议药典持续强化单晶法的理论引领作用,提升粉末法的工业适用性,推动技术融合与数据赋能,加快成熟场景的通则化、各论品种的精准化布局,完善数字化、智能化、全程化的X射线衍射标准体系。
关键词:  X射线衍射  《中国药典》  《美国药典》  《欧洲药典》
DOI:10.13506/j.cnki.jpr.2026.09.013
基金项目:国家重点研发计划项目(No.2023YFC3504102)
收稿日期:2026-06-05   修回日期:2026-07-19   出版日期:2026-09-30
Comparison of the application systems of X-ray diffraction technology in different pharmacopoeias
LIU Guangzhen1,ZHANG Lei1,LIU Qi1,XIAO Jing2
(1.Shandong Engineering Laboratory for Standard Innovation and Quality Evaluation of TCM,Ministry of Industry and Information Technology Industrial Technology Infrastructure Public Service Platform,Shandong Institute for Food and Drug Control,Jinan 250101,China;2.National Institutes for Drug Control,Beijing 102629,China)
Abstract:
This paper systematically reveals the core value and standard development logic of X-ray diffraction technology in pharmaceutical quality control by comparing the application systems of the Chinese, U.S., and European pharmacopoeias. All three pharmacopoeias include the powder X-ray diffraction method and explicitly define its fundamental role in qualitative and quantitative analysis of crystalline substances, establishing unified foundational norms for XRD applications in pharmaceutical quality control. International consensus has been formed in areas such as crystal form identification of drugs, asbestos testing in mineral medicines, and functional property control of pharmaceutical excipients, demonstrating the core value of XRD in pharmaceutical quality control. It is recommended that pharmacopoeias continue to strengthen the theoretical leadership of the single-crystal method, enhance the industrial applicability of the powder method, promote technological integration and data empowerment, accelerate the standardization of mature applications and the precise layout of monograph varieties, and improve the digitalized, intelligent, and comprehensive X-ray diffraction standard system.
Key words:  X-ray diffraction  Chinese Pharmacopoeia  United States Pharmacopeia  European Pharmacopoeia
今日访问量:2484    总访问量:55338922
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司